MoneyWorks4Me

Aurobindo Pharma - Quaterly Results

27 May 2023 Evaluate
The revenue zoomed 22.87% to Rs. 35474.40 millions for the quarter ended March 2023 as compared to Rs. 28871.70 millions during the corresponding quarter last year.The Net proft of the company remain more or less same to Rs. 6448.00  millions from Rs. 8021.60 millions ,decline by -19.62%.OP of the company witnessed a marginal growth to 9800.00 millions from 9203.40 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202303 202203 % Var 202303 202203 % Var 202303 202203 % Var
Sales 35474.40 28871.70 22.87 127922.80 112871.40 13.33 127922.80 112871.40 13.33
Other Income 2881.70 4133.70 -30.29 4337.60 6709.90 -35.36 4337.60 6709.90 -35.36
PBIDT 9800.00 9203.40 6.48 21646.80 21443.90 0.95 21646.80 21443.90 0.95
Interest 489.70 49.10 897.35 1149.80 169.40 578.75 1149.80 169.40 578.75
PBDT 9310.30 8407.20 10.74 20497.00 20527.40 -0.15 20497.00 20527.40 -0.15
Depreciation 1150.00 1012.20 13.61 4353.50 4152.60 4.84 4353.50 4152.60 4.84
PBT 8160.30 7395.00 10.35 16143.50 16374.80 -1.41 16143.50 16374.80 -1.41
TAX 1712.30 -626.60 -373.27 3839.40 1827.70 110.07 3839.40 1827.70 110.07
Deferred Tax -26.10 -880.70 -97.04 -230.80 -1969.30 -88.28 -230.80 -1969.30 -88.28
PAT 6448.00 8021.60 -19.62 12304.10 14547.10 -15.42 12304.10 14547.10 -15.42
Equity 585.90 585.90 0.00 585.90 585.90 0.00 585.90 585.90 0.00
PBIDTM(%) 27.63 31.88 -13.34 16.92 19.00 -10.93 16.92 19.00 -10.93
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..